Last reviewed · How we verify

NCT06653894: PENG vs QLB

Postoperative Analgesic Efficacy of PENG and QLB Blocks in Hip Surgeries

Completed NA Last updated 7 August 2025
What this trial tests

NA trial testing PENG block with 0.25% bupivacaine. in Hip Surgery in 73 participants. Completed in 3 April 2025.

Timeline
25 October 2024
Primary endpoint
1 April 2025
3 April 2025

Quick facts

Lead sponsorGaziosmanpasa Research and Education Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment73
Start date25 October 2024
Primary completion1 April 2025
Estimated completion3 April 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Gaziosmanpasa Research and Education Hospital

Who can join

40 and older, any sex, with Hip Surgery or Postoperative Analgesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective, randomized, single-blinded study compares the postoperative analgesic efficacy of the Pericapsular Nerve Group (PENG) block and Quadratus Lumborum Block (QLB) in hip surgeries under spinal anesthesia. the study focuses on time to first rescue analgesia and total analgesic consumption within the first 48 hours postoperatively in patients over 40 years undergoing elective hip surgery. Ninety patients will be randomized into two groups (PENG or QLB) using a sealed envelope method. The study will assess pain scores, opioid consumption, and side effects, hypothesizing that both blocks provide effective analgesia but seek to identify which offers superior efficacy. Statistical analysis will be performed with SPSS, aiming to contribute valuable insights into analgesic techniques for hip surgeries.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparison of the postoperative analgesic efficacy of pericapsular nerve group block (PENG) and anterior quadratus lumborum block in hip fracture surgery: A prospective randomized study.
    Şehirlioğlu S, Moralar DG. · · 2025 · PMID 41032577 · DOI 10.1177/00368504251382032

Verify or expand the search:

Other trials of PENG block with 0.25% bupivacaine.

Trials testing the same drug.

Other recruiting trials for Hip Surgery

Currently open trials in the same condition.

Other Gaziosmanpasa Research and Education Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06653894.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing